CIK 0001726445
- Non-accelerated filer
- Smaller reporting company
Seer, Inc.
Sign in to watch- Ticker
- SEER
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821153150
- Phone
- +1 650-453-0000
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
- Former names
- Seer Biosciences, Inc.
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Grant or award Director acquired 23,443 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 1,468 shares at $3.56 ($5,224)
- 4 Open-market sale General Counsel and Secretary sold 5,951 shares at $4.13 ($24,603)
- 4 Open-market sale Chief Financial Officer sold 5,951 shares at $4.13 ($24,606)
- 4 Open-market sale CEO, President and Chair sold 13,840 shares at $4.13 ($57,210)
- 4 Grant or award Chief Commercial Officer acquired 70,000 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 70,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 70,000 shares (grant or award)
- 4 Grant or award CEO, President and Chair acquired 402,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 3,124 shares at $5.40 ($16,861)
- 4 Open-market sale CEO, President and Chair sold 8,379 shares at $4.67 ($39,128)
- 4/A Open-market sale CEO, President and Chair sold 4,800 shares at $5.12 ($24,573)
- 4 Open-market sale Chief Financial Officer sold 2,602 shares at $5.12 ($13,320)
- 4 Open-market sale CEO, President and Chair sold 4,800 shares at $5.12 ($24,573)
- 4 Open-market sale Chief Financial Officer sold 18,884 shares at $6.57 ($124,070)
- 4 Exercise or conversion CEO, President and Chair acquired 59,171 shares (option exercise)
Page 4 of 9 · 166 filings